Is US Patent number 5676977 a real viable AIDS cure?
According to the U.S. Patent Office, the claims are that it
is:
1. A method of treating AIDS-afflicted humans comprising
injecting a multitude of tetrasilver tetroxide molecular crystals
into the bloodstream of the human subject.
2. A method for increasing white blood cell counts in
AIDS-afflicted humans comprising injecting a multitude of
tetrasilver tetroxide molecular crystals into the bloodstream of
the human subject.
3. Methods of treating AIDS-affilicted humans according to
claims 1-2 where the concentration of said molecular crystals is
approximately 40 PPM of the total blood weight of the human
subject.
This does not necessarily mean it is a cure.
To read more, visit the U.S. Patent site at the Related
Link.